NCT02603783View on ClinicalTrials.gov

Esophageal capsaïcin Infusion and Mucosal Integrity

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
TRPV1 Protein, HumanCapsaicinElectric ImpedanceEsophagusIntracellular SpacePain MeasurementMicroscopy, Electron
Interventions
OTHER

Capsaicin

capsaicin 1,5 mg

OTHER

Placebo

0,9% saline 75 ml

Trial Locations (1)

6229 HX

Maastricht University, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT02603783 - Esophageal capsaïcin Infusion and Mucosal Integrity | Biotech Hunter | Biotech Hunter